The Clinical Trials on Alzheimer’s Disease (CTAD) conference took place in San Diego (USA), from 1 to 4 December 2025. We provide some links to our selected highlights about the event and the research presented:
1 December, Roche presents new data with trontinemab at CTAD25
2 December, New results from the US POINTER study were presented at CTAD25
3 December, ALZ-NET investigators present first data readout of registry for new AD treatments in the US
3 December, Results of EVOKE and EVOKE+ trials show no effect of oral semaglutide on AD progression
4 December, Eisai presents new data on lecanemab maintenance treatment in early AD